CJ cheiljedang's incrementally modified drug for diabetes treatment 'Vogmet' recently acquired a patent
CJ cheiljedang's incrementally modified drug for diabetes treatment 'Vogmet (Voglibose + Metformin)' recently acquired a patent from the Korean Intellectual Property Office, getting the recognition of improving hypoglycemia and gastrointestinal side effects.
In this patent, Vogmet received rec...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
